PPARG and cancer: PPAR-γ has been known for its anti-inflammatory properties, majorly contributed by the reduction of inflammatory cytokines; in a tumor microenvironment, tumor-associated inflammation could result in immune suppression involving T regulatory cells and myeloid-derived suppressor cells (MDSC), whose accumulation is a great threat to a successful cancer treatment.